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QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF SOME  
1-BENZYL BENZIMIDAZOLE DERIVATIVES AS ANTIFUNGAL AGENTS 
 
Sanja O. Podunavac-Kuzmanovi 
1, Dijana J. Barna, Dragoljub D. Cvetkovi   
 
  In the present study, the antifungal activity of some 1-benzylbenzimidazole derivatives 
against yeast Saccharomyces cerevisiae was investigated. The tested benzimidazoles 
displayed in vitro antifungal activity and minimum inhibitory concentration (MIC) was 
determined for all the compounds. Quantitative structure-activity relationship (QSAR) has 
been used to study the relationships between the antifungal activity and lipophilicity 
parameter, logP, calculated by using CS Chem-Office Software version 7.0. The results are 
discussed on the basis of statistical data. The best QSAR model for prediction of anti-
fungal activity of the investigated series of benzimidazoles was developed. High agreement 
between experimental and predicted inhibitory values was obtained. The results of this 
study indicate that the lipophilicity parameter has a significant effect on antifungal activity 
of this class of compounds, which simplify design of new biologically active molecules. 
KEY WORDS:  1-Benzylbenzimidazole, lipophilicity, antifungal activity, quantitative 
structure-activity relationship, in vitro studies. 
 
 
INTRODUCTION 
 
  Benzimidazoles are a group of molecules which have shown potential for application 
in a variety of pharmacological targets. They are of wide interest because of their diverse 
biological activity and clinical applications.  Biologically active benzimidazoles have 
been known for a long time and they can act as bacteriostats or bactericides, as well as 
fungicides (1-9). This ring system was proved to be very important as it is involved in 
numerous antiparasitic, antitumoral and antiviral drugs (10,11). It is also well known that 
these molecules are present in a variety of antioxidant and antiallergic agents (12-14). 
Many derivatives of benzimidazole show antiparasitic (15) and antiprotozoal (16) acti-
vities. In recent years, benzimidazole derivatives have attracted particular interest due to 
their anticancer activity or as potential in vitro anti-HIV agents (17-18). 
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  A large number of research studies are needed to analyze the pharmacophore present 
in these compounds using the Three Dimensional QSAR methods (19-20). The under-
standing of the role of chemical structure in biological activity is very important. Predic-
tions of biological and physicochemical properties of molecules from their structures are 
the fundamental and one of the most interesting objectives of chemistry. The physico-
chemical properties predicted from structure are helpful in the search for new molecules 
of similar or increased biological activity. QSAR studies enable the investigators to es-
tablish reliable quantitative structure-activity relationships, to derive a QSAR model and 
predict the activity of novel molecules prior to their synthesis. These studies reduce the 
trial- and error element in the design of compounds by establishing mathematical rela-
tionships between physical, chemical, biological, or environmental activities of interest 
and measurable or computable parameters such as physicochemical, electronic, topolo-
gical, or stereochemistry. 3D-QSAR methodology has been successfully used to generate 
models for various chemotherapeutic agents.  
  Octanol-water partition coefficient, referred to as logP, is a frequently used parameter 
in organic synthetic chemistry (21-22). It is a quantitative descriptor of lipophilicity, one 
of the key determinants of pharmacokinetic properties. LogP is commonly used in QSAR 
studies and drug design, since this property is related to drug absorption, metabolism, 
bioavailability, and toxicity. This parameter is also used in many environmental studies to 
determine the environmental fate of chemicals. By knowing exact values for this parame-
ter, it is possible to predict the inhibitory activity of a drug. 
  In this context, the aim of the present study was to investigate the activity of different 
substituted 1-benyzlbenzimidazoles against yeast Saccharomyces cerevisiae and study 
the quantitative effect of lipophilicity on antifungal activity. The main objective was to 
establish a quantitative lipophilicity-inhibitory activity relationships and derive a high-
quality model which would link the lipophilicity of these compounds with their inhibitory 
activity. 
 
 
EXPERIMENTAL 
 
Molecules 
 
  The structures of the benzimidazoles tested in this study are presented in Table 1. The 
investigated compounds were synthesized by a procedure described earlier (23). 
 
Antifungal activity 
 
  All the benzimidazole derivatives were tested for their in vitro growth inhibition 
activity against yeast Saccharomyces cerevisiae (ATCC 24860). For the evaluation of the 
antifungal activities of the samples, agar disc diffusion method was used as described by 
NCCLS (24).  
  The strains were grown on Sabouraud Dextrose slants for 24 hours at 25
 oC and 
checked for purity. After incubation the cells were washed from the surface of agar and 
suspended in a sterile phisyological solution. The number of cells in 1 cm
3 of suspension 
for inoculation, measured by Mc Farland nephelometer, was 110
7 cfu cm
-3. The 1 cm
3 of 
this suspensions was homogenized with 9 cm
3 of melted (45
oC) Sabouraud Dextrose  
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Agar and poured into Petri dishes. On the surface of the agar the 6 mm diameter sterile 
paper discs (Hi Media, Mumbai, India) were put and impregnated with 10
-3 cm
3 of sam-
ples. 
 
Table 1. The structures of the compounds studied 
 
 
 
 
Compound R1 R 2 R 3 R 4 
I-CH3  CH3 H CH3 CH3 
I-Cl Cl  H  CH3 CH3 
I-F F  H  CH3 CH3 
I-OCH3 OCH3 H  CH3 CH3 
II-CH3  CH3 NH2 H  H 
II-Cl Cl  NH2 H  H 
II-F F  NH2 H  H 
II-OCH3 OCH3 NH2 H  H 
III-CH3 CH3 NH2 CH3 CH3 
III-Cl Cl  NH2 CH3 CH3 
III-F F  NH2 CH3 CH3 
III-OCH3 OCH3 NH2 CH3 CH3 
 
  The plates were incubated for 24-47 hours at 25 
oC, and the diameter of the resulting 
inhibition zone (including the disc) was measured (in mm). The evaluation of antifungal 
activities of samples was carried out in three repetitions. 
  Minimum inhibitory concentration (MIC) was determined by the agar dilution me-
thod according to guidelines established by the NCCLS standard M7-A5 (25). The MIC 
of tested benzimidazoles is defined as the lowest concentration of the compound at which no 
growth of the strain is observed in time and under specified experimental conditions. Stock 
solutions of the compounds were prepared in dimethylformamide (DMF). Further dilu-
tions were performed with distilled water. The inoculated plates were then incubated at 
35
oC for 16-20 h. A control (using DMF without any test compound) was included for 
each organism. It was determined that the solvent had no activity against any of the test 
microorganisms. The negative logarithms of molar MICs (log1/cMIC) were determined and 
used for further calculations. 
R3
R4 N
N
R  2
CH2
R1 
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Molecular Modelling and logP Calculations 
 
  Molecular modelling studies were performed by using CS Chem-Office Software ver-
sion 7.0 (Cambridge software) running on a P-III processor (26). All molecules were 
constructed by using Chem Draw Ultra 7.0 and saved as the template structure. For every 
compound, the template structure was suitably changed considering its structural features, 
copied to Chem 3D 7.0 to create a 3-D model and, finally, the model was cleaned up and 
subjected to energy minimization using molecular mechanics (MM2). The minimization 
was executed until the root mean square (RMS) gradient value reached a value smaller 
than 0.1 kcal/molA. The Austin Model-1 (AM-1) method was used for re-optimization 
until the RMS gradient attained a value smaller than 0.0001 kcal/molA using MOPAC. 
The lowest energy structure was used for each molecule to calculate lipophilicity para-
meters (Table 2). 
 
Table 2. Data of the lipophilicity parameters used in this study and the experimental and 
predicted values of  log1/cMIC 
 
Lipophilicity  Antifungal activity  
Compound 
logP  Log1/cMIC 
exper. 
log1/cMIC 
predict.  Residuals 
I-CH3  4.24 4.604  4.595  0.009 
I-Cl  4.31 4.638  4.612  0.026 
I-F  3.91 4.611  4.657  -0.046 
I-OCH3  3.63 4.330  4.268  0.062 
II-CH3  3.44 3.971  4.003  -0.032 
II-Cl  3.52 4.316  4.276  0.040 
II-F  3.11 3.685  3.757  -0.072 
II-OCH3  2.83 3.405  3.368  0.037 
III-CH3  4.42 4.629  4.631  -0.002 
III-Cl  4.49 4.662  4.638  0.024 
III-F  4.09 4.335  4.343  -0.008 
III-OCH3  3.80 4.354  4.390  -0.036 
 
 
Statistical Methods 
 
  The complete regression analysis was carried out by PASS 2005, GESS 2006, NCSS 
Statistical Softwares (27).  
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RESULTS AND DISCUSSION 
 
  The results of antifungal studies of 1-benzylbenzimidazoles against Saccharomyces ce-
revisiae are summarized in Table 2. As indicated, all the compounds show noteworthy 
antifungal activities against the tested yeast. Consequently, compounds with high 
log1/cMIC (or low MIC) are the best antifungals. 
  In this study, the log1/cMIC values were correlated against logP parameters calculated 
by using CS Chem-Office Software. Usually, the lipophilicity parameters are linearly 
related to the biological activity (MICs), but in a more general case this relationship is not 
linear.  
  Therefore, a complete regression analysis resorting to linear, quadratic and cubic re-
lationships (Table 3) was made. It is apparent, from the correlation coefficients (r), that 
fitting equation improves when resorting to higher order (second or third) polynomials.  
  The statistical quality of the regression equations was justified by the parameters such 
as correlation coefficient (r), square of adjusted correlation coefficient (r
2
adj), standard 
error of estimate (s), square of cross-validation coefficient (Q
2) and probability factor 
related to F-ratio. Statistical data presented in Table 3 indicate that very good nonlinear 
equations were obtained.  
  For the estimation of the quality with regard to predictive ability of this model, the 
cross-validation statistical technique has been applied. This is the most common valida-
tion technique, where a number of modified data sets are created by deleting, in each 
case, one or smaller group of objects from the data in such a way that each object is taken 
away once and only once. For each reduced data set, the model is calculated, and respon-
ses for the deleted objects are predicted from the model. 
  The simplest and most general cross-validation procedure is the leave-one-out tech-
nique (LOO technique) (28). This method uses cross-validated fewer parameters: PRESS 
(predicted residual sum of squares), SSY (total sum of squares deviation), Q
2 and r
2
adj. 
PRESS is an important cross-validation parameter as it is a good approximation of the 
real predictive error of the models. Its value being less than SSY points out that the mo-
del predicts better than chance and can be considered statistically significant. The present 
models have PRESS<<SSY. From the PRESS and SSY, Q
2 can be easily calculated: 
 
Q
2= 1 - PRESS/SSY                               1 
 
 The  high  Q
2 value observed for quadratic QSAR model is indicative of its reliability 
in prediction of inhibitory activity. For the verification of the predictive power of the 
developed model, predicted log1/cMIC values of benzimidazoles investigated were calcu-
lated by using quadratic equation and compared with the experimental values (Table 2). 
Based on the magnitude of residue, there is a high agreement between the observed and 
calculated inhibitory activity. All the presented results suggest dependence of the lipo-
philicity parameters on biological behaviour of benzimidazoles investigated. By knowing 
exact values of these parameters, we can accurately predict inhibitory activity. 
  The derived relationship between lipophilicity parameters and inhibitory activity can 
be used for estimating the antifungal activity of other benzimidazoles. The results illu-
strate that the regression technique is adequate to create fine QSAR model for predicting 
the inhibitory activity of different compounds, which is useful for drug design and medi-
cinal chemistry.  
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CONCLUSIONS 
 
  QSAR analysis was performed to estimate the quantitative effects of the lipophilicity 
parameters, logP, of the different substituted 1-benzylbenzimidazoles on their antifungal 
activity against Saccharomyces cerevisiae. logP values were calculated for each mole-
cule, and three high-quality mathematical models relating the inhibitory activity, 
log1/cMIC, and logP  were defined.. For the estimation of the predictive ability of these 
models, the cross-validation statistical technique was applied. Comparison of the linear, 
quadratic and cubic relationships showed that the quadratic equation was the most 
appropriate for prediction of antifungal activity of the investigated class of molecules. It 
is concluded that the lipophilicity parameter is a convenient quantity for modelling inhi-
bition for the present set of benzimidazole derivatives. The developed QSAR mathema-
tical model is used to predict inhibitory activity of the benzimidazoles investigated, and a 
high agreement between experimental and predicted values was obtained. It indicates that 
this model can be successfully applied to predict the antifungal activity of  this class of 
molecules.  
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